In a randomized, phase 3, open-label trial comparing two oral GLP-1 receptor agonists, a greater percentage of adults receiving orforglipron 12 mg or 36 mg (Eli Lilly) were able to achieve an HbA1c of less than 7%, 6.5% and 5.7% vs
doi: 10.3390/antiox10071025 212 ChenYMTuCJHungKYWuKDTsaiTJHsiehBS
Can I Combine Dihexa with Other Cognitive Enhancers
Obese class III, MASLD and/or higher-risk metabolic phenotypes resistant to incretin drug effects
That guidance may include: confirming whether the medication is appropriate in the first place reviewing contraindications and risk factors discussing expected side effects and red flags setting realistic dosing and escalation plans helping with hydration and protein intake identifying when exercise should be modified, not abandoned following outcomes beyond just pounds lost For some patients, that broader structure is best delivered through a Medical Weight Loss Program
ALCAR Clinical Research In one study, researchers showed that ALCAR may have beneficial effects for depression and dementia in the aging brain.[x] Another study out of Italy